- Q4 2023 Alector Inc Earnings Call TranscriptFeb 27, 2024€5.85 (+1.74%)Earnings
- Alector Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Alector Inc Earnings Call TranscriptAug 03, 2023€6 (-1.64%)Earnings
- Alector Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- H.C. Wainwright with Alector TranscriptMay 24, 2023
- Alector Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Alector Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Alector Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Alector Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Alector Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Alector Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Alector Inc to Present New AL001 Data- Conference Call TranscriptMar 15, 2022
- Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVROBIO Inc and Annexon Inc in the Orphan CNS Panel at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Alector Inc to Present to Discuss Data Presented at 2021 Clinical Trials on Alzheimer's Disease Meeting TranscriptNov 12, 2021
- Alector Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Alector Inc at Citi BioPharma Conference (Virtual)- Panel: What's Next for Neurodegenerative Diseases TranscriptSep 08, 2021
- Alector Inc to Review the AL001 Phase 2 Results- Conference Call TranscriptJul 29, 2021
- Alector Inc to Discuss Collaboration with GlaxoSmithKline PLC for AL001 & AL101 Call TranscriptJul 02, 2021
- Alector Inc at Bank of America NAPA Healthcare Conference TranscriptJun 14, 2021
- Alector Inc to Host Virtual Key Opinion Leader Event on Frontotemporal Dementia TranscriptJun 11, 2021
- Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Alector Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Alector Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Alector Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Alector Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Alector Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Alector Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Alector, Inc. - Special Call TranscriptDec 13, 2019
- Alector Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Alector Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
Alector, Inc. - Special Call Transcript
Good morning, everybody. Thank you all for being here. We're very appreciative of all of you that are here in person in a packed room and for those of you that are dialing in, really appreciate especially potentially from West Coast, 5 am in the morning. So let's get this started. I'm Sabah, I'm the Chief Business Officer at Alector, and I've been with the team for about 4 years now, and welcome to our first, and what we hope to be, Annual Research and Development Day.
I will be your MC. I'll kick things off. And quickly, I'll be handing it over to Arnon, who's our CEO and Co-Founder.
Really quickly. The speakers today are Arnon; Robert Paul, who is our Chief Medical Officer, I'll do a quick section on the corporate strategy. And then we have 3 key opinion leaders in neurodegeneration. Dr. Masellis from Sunnybrook Health Sciences Centre; Dr. Bradshaw from Columbia University; and Dr. Cruchaga from Washington University in St. Louis. They will be going over specific sections in our presentation as well and giving you the research
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)